Stanley Capital-backed DSS, Drug Safety and Pharmacovigilance Services Solutions company, completed the acquisition of MyMeds&Me, a pharmacovigilance solutions provider. Financial terms were not disclosed. “MyMeds&Me is proud to be joining the DSS family, providing us with a framework to expand our high-quality technology offering. With the industry’s ever greater focus on patient engagement, the deployment of innovative technology combined with complementary services from DSS will enable our customers to revolutionise their pharmacovigilance strategy and optimise the safe use of their medicines," Andrew Rut, MMM CEO and Founder.